Acclarent, Inc. · Menlo Park, CA United States
Company Description
View Acclarent, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Acclarent's medical technology helps people breathe easy without surgery. The company created the Balloon Sinuplasty, a minimally-invasive device used to treat patients with chronic sinusitis. The Balloon Sinuplasty opens blocked sinuses by inflating a balloon in the sinus cavity instead of cutting away bone and tissue, and patients can return to work as soon as the next day. The device received FDA approval in 2005 and is marketed directly to ear, nose, and throat (ENT) doctors in the US and the UK. Acclarent filed to go public in June 2008 and plans to use the proceeds from its IPO for additional sales and marketing of the Balloon Sinuplasty, as well as training physicians on the device. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Acclarent, Inc. Financials
| Company Type | Private Single Location |
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $22.2 |
| 2007 Employees | 210 |
Acclarent, Inc. Executives
20 executives listed for Acclarent, Inc.'s Menlo Park, CA location.
| Title | Name & Bio | Contact |
| Chairman | Joshua Makower | Network |
| President, CEO, and Director | William Facteau | Network |
| COO and General Counsel | Greg Garfield | Network |
Competition
Competitive Landscape for Acclarent, Inc.
Demand is driven by population demographics and advances in medical knowledge and technology. The profitability of individual companies depends on the ability to develop superior products. Large companies have economies of scale in manufacturing and R&D. Small companies can compete successfully by specializing in a particular market segment, or through technical innovation. To read the full description, subscribe now.Top Acclarent, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!